...
search icon
nage-img

Niagen Bioscience, Inc. Share Price

NAGE
NAQ
$5.09
-$0.02
(-0.39%)
1D
Industry: Life Sciences Tools & Services Sector: Health Care

Niagen Bioscience, Inc. Analyst Forecast

Niagen Bioscience, Inc. Share Price Chart

Niagen Bioscience, Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$407.81M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
21.2917
Volume info-icon
This is the total number of shares traded during the most recent trading day.
650.65K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.09
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.92 L
$14.69 H
$5.09

About Niagen Bioscience, Inc., Common Stock

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Niagen Bioscience, Inc. Stock Returns

Time FrameNAGESectorS&P500
1-Week Return-0.78%0.91%2.13%
1-Month Return-20.34%-0.72%-0.47%
3-Month Return-29.11%2.24%1.29%
6-Month Return-50.39%19.1%7.71%
1-Year Return-7.12%7.15%14.7%
3-Year Return173.66%16.96%67.75%
5-Year Return-5.91%33.23%76.25%
10-Year Return33.6%142.74%271.83%

Niagen Bioscience, Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue59.26M67.45M72.05M83.57M99.60M[{"date":"2020-12-31","value":59.5,"profit":true},{"date":"2021-12-31","value":67.72,"profit":true},{"date":"2022-12-31","value":72.34,"profit":true},{"date":"2023-12-31","value":83.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue23.98M25.96M29.25M32.79M38.01M[{"date":"2020-12-31","value":63.09,"profit":true},{"date":"2021-12-31","value":68.29,"profit":true},{"date":"2022-12-31","value":76.96,"profit":true},{"date":"2023-12-31","value":86.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit35.27M41.49M42.80M50.78M61.59M[{"date":"2020-12-31","value":57.28,"profit":true},{"date":"2021-12-31","value":67.37,"profit":true},{"date":"2022-12-31","value":69.49,"profit":true},{"date":"2023-12-31","value":82.45,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin59.53%61.51%59.40%60.76%61.84%[{"date":"2020-12-31","value":96.27,"profit":true},{"date":"2021-12-31","value":99.48,"profit":true},{"date":"2022-12-31","value":96.06,"profit":true},{"date":"2023-12-31","value":98.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses55.13M68.56M61.42M56.38M53.86M[{"date":"2020-12-31","value":80.4,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.59,"profit":true},{"date":"2023-12-31","value":82.23,"profit":true},{"date":"2024-12-31","value":78.56,"profit":true}]
Operating Income(19.85M)(27.07M)(18.63M)(5.60M)7.73M[{"date":"2020-12-31","value":-256.98,"profit":false},{"date":"2021-12-31","value":-350.41,"profit":false},{"date":"2022-12-31","value":-241.11,"profit":false},{"date":"2023-12-31","value":-72.47,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense-(110.00K)2.09M1.32M2.26M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4.87,"profit":false},{"date":"2022-12-31","value":92.6,"profit":true},{"date":"2023-12-31","value":58.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(19.93M)(27.13M)(16.54M)(4.94M)8.86M[{"date":"2020-12-31","value":-225.01,"profit":false},{"date":"2021-12-31","value":-306.36,"profit":false},{"date":"2022-12-31","value":-186.79,"profit":false},{"date":"2023-12-31","value":-55.77,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes----305.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes----8.55M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations-(27.13M)(16.54M)(4.94M)8.55M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-317.29,"profit":false},{"date":"2022-12-31","value":-193.45,"profit":false},{"date":"2023-12-31","value":-57.75,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(19.93M)(27.13M)(16.54M)(4.94M)8.55M[{"date":"2020-12-31","value":-233.04,"profit":false},{"date":"2021-12-31","value":-317.29,"profit":false},{"date":"2022-12-31","value":-193.45,"profit":false},{"date":"2023-12-31","value":-57.75,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(0.33)(0.41)(0.23)(0.07)0.12[{"date":"2020-12-31","value":-284.1,"profit":false},{"date":"2021-12-31","value":-354.36,"profit":false},{"date":"2022-12-31","value":-198.79,"profit":false},{"date":"2023-12-31","value":-59.2,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Niagen Bioscience, Inc. Ratios

Niagen Bioscience, Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NAGE
Cash Ratio 2.82
Current Ratio 4.12
Quick Ratio 3.29

Niagen Bioscience, Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NAGE
ROA (LTM) 15.60%
ROE (LTM) 38.90%

Niagen Bioscience, Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NAGE
Debt Ratio Lower is generally better. Negative is bad. 0.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.72

Niagen Bioscience, Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NAGE
Trailing PE 21.29
Forward PE 17.04
P/S (TTM) 3.27
P/B 5.78
Price/FCF 111
EV/R 2.78
EV/Ebitda 16.73

FAQs

What is Niagen Bioscience, Inc. share price today?

Niagen Bioscience, Inc. (NAGE) share price today is $5.09

Can Indians buy Niagen Bioscience, Inc. shares?

Yes, Indians can buy shares of Niagen Bioscience, Inc. (NAGE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NAGE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Niagen Bioscience, Inc. be purchased?

Yes, you can purchase fractional shares of Niagen Bioscience, Inc. (NAGE) via the Vested app. You can start investing in Niagen Bioscience, Inc. (NAGE) with a minimum investment of $1.

How to invest in Niagen Bioscience, Inc. shares from India?

You can invest in shares of Niagen Bioscience, Inc. (NAGE) via Vested in three simple steps:

  • Click on Sign Up or Invest in NAGE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Niagen Bioscience, Inc. shares
What is Niagen Bioscience, Inc. 52-week high and low stock price?

The 52-week high price of Niagen Bioscience, Inc. (NAGE) is $14.69. The 52-week low price of Niagen Bioscience, Inc. (NAGE) is $4.92.

What is Niagen Bioscience, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Niagen Bioscience, Inc. (NAGE) is 21.2917

What is Niagen Bioscience, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Niagen Bioscience, Inc. (NAGE) is 5.78

What is Niagen Bioscience, Inc. dividend yield?

The dividend yield of Niagen Bioscience, Inc. (NAGE) is 0.00%

What is the Market Cap of Niagen Bioscience, Inc.?

The market capitalization of Niagen Bioscience, Inc. (NAGE) is $407.81M

What is Niagen Bioscience, Inc.'s stock symbol?

The stock symbol (or ticker) of Niagen Bioscience, Inc. is NAGE

How Can Investors Use Niagen Bioscience, Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Niagen Bioscience, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Niagen Bioscience, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Niagen Bioscience, Inc. shares for Indian investors?

When investing in Niagen Bioscience, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Niagen Bioscience, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Niagen Bioscience, Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Niagen Bioscience, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Niagen Bioscience, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top